MCM
VCYT icon

Manchester Capital Management’s Veracyte VCYT Stock Holding History

Manchester Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-37
Closed -$1K – 1135
2021
Q2 		$1K Buy
+37
New +$1.58K ﹤0.01% 780

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Manchester Capital Management's VCYT Position: Q3 2021 in Review

Manchester Capital Management sold out of Veracyte (VCYT) in Q3 2021, closing a stake of 37 shares — an estimated $1K sold.

Manchester Capital Management first reported a position in VCYT in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 214 funds tracked by Wall St. Rank hold VCYT as of Q3 2021.

  • Manchester Capital Management reported no remaining Veracyte position as of Q3 2021 after selling out during the quarter.
  • Manchester Capital Management sold 37 Veracyte shares in Q3 2021, an estimated $1K.
  • Manchester Capital Management first reported a position in Veracyte in Q2 2021 and held it in 1 quarter.
  • Manchester Capital Management's Veracyte position peaked at $1K in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q3 2021.

Based on Manchester Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.